Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -0.96%103.91K | -13.08%468.77K | 2.31%152.45K | -40.17%104.74K | -7.89%106.67K | 5.60%104.92K | 11.05%539.28K | -5.06%149K | 59.22%175.06K | 0.60%115.8K |
| Selling and administrative expenses | -1.00%90K | -17.68%398.25K | -1.10%131.21K | -45.10%90K | -8.96%86.13K | -1.80%90.91K | 16.31%483.79K | -4.19%132.67K | 82.15%163.93K | -0.67%94.61K |
| -General and administrative expense | -1.00%90K | -17.68%398.25K | -1.10%131.21K | -45.10%90K | -8.96%86.13K | -1.80%90.91K | 16.31%483.79K | -4.19%132.67K | 82.15%163.93K | -0.67%94.61K |
| Research and development costs | -4.80%8.93K | 81.88%36.15K | -25.00%8.93K | 50.00%8.93K | ---- | 235.89%9.38K | -45.02%19.88K | 33.30%11.9K | -33.33%5.95K | ---- |
| Other operating expenses | 7.50%4.99K | -3.53%34.36K | 177.85%12.31K | 12.38%5.81K | -3.11%20.54K | -66.11%4.64K | 6.18%35.62K | -53.60%4.43K | -53.08%5.17K | 98.28%21.19K |
| Operating profit | 0.96%-103.91K | 13.08%-468.77K | -2.31%-152.45K | 40.17%-104.74K | 7.89%-106.67K | -5.60%-104.92K | -11.05%-539.28K | 5.06%-149K | -59.22%-175.06K | -0.60%-115.8K |
| Net non-operating interest income (expenses) | -762.20%-11.31K | -54.78%-30.43K | -71.05%-26.49K | 0.08%-1.31K | 15.14%-1.31K | 0.00%-1.31K | 3.21%-19.66K | 11.49%-15.49K | -40.13%-1.31K | -64.82%-1.55K |
| Non-operating interest expense | 762.20%11.31K | 54.78%30.43K | 71.05%26.49K | -0.08%1.31K | -15.14%1.31K | 0.00%1.31K | -3.21%19.66K | -11.49%15.49K | 40.13%1.31K | 64.82%1.55K |
| Other net income (expenses) | -20.45K | |||||||||
| Special income (charges) | --0 | --0 | ---- | ---- | ---- | --0 | ---20.45K | ---- | ---- | ---- |
| -Less:Impairment of capital assets | --0 | --0 | ---- | ---- | ---- | --0 | --20.45K | ---- | ---- | ---- |
| Income before tax | -8.46%-115.22K | 13.84%-499.19K | 3.24%-178.94K | 39.87%-106.05K | 7.98%-107.98K | -5.53%-106.23K | -14.52%-579.39K | -6.02%-184.94K | -59.06%-176.37K | -1.12%-117.35K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -8.46%-115.22K | 13.84%-499.19K | 3.24%-178.94K | 39.87%-106.05K | 7.98%-107.98K | -5.53%-106.23K | -14.52%-579.39K | -6.02%-184.94K | -59.06%-176.37K | -1.12%-117.35K |
| Net income continuous operations | -8.46%-115.22K | 13.84%-499.19K | 3.24%-178.94K | 39.87%-106.05K | 7.98%-107.98K | -5.53%-106.23K | -14.52%-579.39K | -6.02%-184.94K | -59.06%-176.37K | -1.12%-117.35K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -8.46%-115.22K | 13.84%-499.19K | 3.24%-178.94K | 39.87%-106.05K | 7.98%-107.98K | -5.53%-106.23K | -14.52%-579.39K | -6.02%-184.94K | -59.06%-176.37K | -1.12%-117.35K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -8.46%-115.22K | 13.84%-499.19K | 3.24%-178.94K | 39.87%-106.05K | 7.98%-107.98K | -5.53%-106.23K | -14.52%-579.39K | -6.02%-184.94K | -59.06%-176.37K | -1.12%-117.35K |
| Diluted earnings per share | 0 | 0.00%-0.01 | 0.00%-0.003 | 0.00%-0.002 | 0.00%-0.002 | 0 | 0.00%-0.01 | 25.00%-0.003 | 0.00%-0.002 | 0.00%-0.002 |
| Basic earnings per share | 0 | 0.00%-0.01 | 0.00%-0.003 | 0.00%-0.002 | 0.00%-0.002 | 0 | 0.00%-0.01 | 25.00%-0.003 | 0.00%-0.002 | 0.00%-0.002 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.